slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 29,671-29,700
Pages 1,371
Rows per page 30
Component
29,671-29,700 of 41,127
05
The table uses a waterfall-style logic to explain the variance between two periods.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
15
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations 1 hit
18
The table includes a footnote clarifying the adjusted basis for specific segments.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations 1 hit
12
The slide uses a combination of big numbers and stacked bar charts to visualize cumulative growth over time.AbCellera | Results Presentation Deck | 18 slides · AbCellera
Conference presentation Investor relations 1 hit
02
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
28
Includes survival curve (Kaplan-Meier) and pharmacodynamic response (tHcy levels over time).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
29
Includes histological images of liver tissue and a dot plot showing bone mineral density (BMD) improvement.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
34
Includes a study design timeline at the bottom right and MCID reference lines on the GMFM-E chart.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
04
The slide uses a three-column layout to categorize targets by product and financial performance.Theravance Biopharma | Investor Conference Presentation Deck | 32 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Key MessagesLoop · Quick Win Big Bet1 hit
08
The slide uses a timeline-based study design diagram.Theravance Biopharma | Investor Conference Presentation Deck | 32 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
27
The funnel visualizes the drop-off from total diagnosed COPD patients to those currently on YUPELRI.Theravance Biopharma | Investor Conference Presentation Deck | 32 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
The slide serves as a reference or bibliography page for clinical study presentations.Theravance Biopharma | Investor Conference Presentation Deck | 32 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
30
Includes a detailed table for Trelegy Ellipta milestones and royalty projections.Theravance Biopharma | Investor Conference Presentation Deck | 32 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
02
thredUP | Investor Presentation Deck | 33 slidesthredUP | Investor Presentation Deck | 33 slides · thredUP
Pitch deck Investor relations 1 hit
05
The slide uses a three-column layout to categorize company facts, financial performance, and sustainability impact.thredUP | Investor Presentation Deck | 33 slides · thredUP
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a legend for office vs distribution center locations.thredUP | Investor Presentation Deck | 33 slides · thredUP
Pitch deck Investor relations Beat · Solution1 hit
17
Includes a footnote regarding the reporting period.thredUP | Investor Presentation Deck | 33 slides · thredUP
Pitch deck Investor relations 1 hit
27
Includes a disclaimer about SBC expense exclusion.thredUP | Investor Presentation Deck | 33 slides · thredUP
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
30
The table provides a detailed financial breakdown of operating expenses by category, including YoY growth and percentage of revenue metrics.thredUP | Investor Presentation Deck | 33 slides · thredUP
Pitch deck Investor relations 1 hit
02
UBS | Results Presentation Deck | 28 slidesUBS | Results Presentation Deck | 28 slides · UBS
Conference presentation Investor relations Beat · Attention1 hit
10
The chart uses a break in the Y-axis to accommodate the large starting and ending values relative to the smaller variance bars.UBS | Results Presentation Deck | 28 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
The slide contrasts reported and underlying financial metrics for 1Q23.UBS | Results Presentation Deck | 28 slides · UBS
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
24
Includes a detailed disclaimer regarding allocation methodology and exclusions of Group-level items.UBS | Results Presentation Deck | 28 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
28
Standard corporate legal disclaimer for financial presentations.UBS | Results Presentation Deck | 28 slides · UBS
Conference presentation Investor relations Beat · Action1 hit
02
Unilever | Results Presentation Deck | 19 slidesUnilever | Results Presentation Deck | 19 slides · Unilever
Conference presentation Investor relations 1 hit
04
The slide uses a 2x2 grid layout to present four key financial metrics.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
05
The slide uses horizontal bar charts to compare three years of financial data across four key metrics.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Key Performance Indicators OverviewLoop · Logic Chain1 hit
08
Waterfall chart shows the bridge from FY 2021 to FY 2022 revenues.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations 1 hit
12
Includes disclaimer regarding non-IFRS financial measures.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Evidence1 hit
13
Includes a disclaimer regarding Non-IFRS financial measures.Zegna | Results Presentation Deck | 36 slides · Ermenegildo Zegna Group
Conference presentation Investor relations Beat · Evidence1 hit